| Efficacy of interferon alpha for the treatment of hospitalized patients with COVID-19: A meta-analysis M Buchynskyi, I Kamyshna, K Lyubomirskaya, O Moshynets, N Kobyliak, ... Frontiers in Immunology 14, 1069894, 2023 | 23 | 2023 |
| Therapeutic effectiveness of interferon-α2b against COVID-19 with community-acquired pneumonia: the Ukrainian experience A Kamyshnyi, H Koval, O Kobevko, M Buchynskyi, V Oksenych, D Kainov, ... International journal of molecular sciences 24 (8), 6887, 2023 | 16 | 2023 |
| The Intersection of COVID-19 and Metabolic-Associated Fatty Liver Disease: An Overview of the Current Evidence M Buchynskyi, I Kamyshna, V Oksenych, N Zavidniuk, A Kamyshnyi Viruses 15 (5), 1072, 2023 | 10 | 2023 |
| Genetic Predictors of Comorbid Course of COVID-19 and MAFLD: A Comprehensive Analysis M Buchynskyi, V Oksenych, I Kamyshna, SG Vari, A Kamyshnyi Viruses 15 (8), 1724, 2023 | 9 | 2023 |
| Exploring Paxlovid Efficacy in COVID-19 Patients with MAFLD: Insights from a Single-Center Prospective Cohort Study M Buchynskyi, V Oksenych, I Kamyshna, O Kamyshnyi Viruses 16 (1), 112, 2024 | 5 | 2024 |
| Genomic insight into COVID-19 severity in MAFLD patients: a single-center prospective cohort study M Buchynskyi, V Oksenych, I Kamyshna, O Budarna, I Halabitska, ... Frontiers in genetics 15, 1460318, 2024 | 2 | 2024 |
| Modulatory Roles of AHR, FFAR2, FXR, and TGR5 Gene Expression in Metabolic-Associated Fatty Liver Disease and COVID-19 Outcomes M Buchynskyi, V Oksenych, I Kamyshna, I Vorobets, I Halabitska, ... Viruses 16 (6), 985, 2024 | 2 | 2024 |
| Modulatory Roles of AHR, FFAR2, FXR, and TGR5 Gene Expression in MAFLD and COVID-19 Outcomes M Buchynskyi, V Oksenych, I Kamyshna, I Vorobets, O Kamyshnyi Preprints, 2024 | | 2024 |
| Association between metabolic-associated fatty liver disease and Covid-19 severity: A genetic analysis MV Buchynskyi, OM Kamyshnyi Biopolymers and Cell 40 (3), 224-224, 2024 | | 2024 |
| Pharmacogenetics Determinants of Paxlovid Response: The Role of IFNAR2, OAS1, OAS3, and ACE2 in Modulating COVID-19 Patient Outcomes M Buchynskyi, V Oksenych, I Kamyshna, I Halabitska, O Kamyshnyi | | 2024 |
| The intersection of COVID-19 and MAFLD: An overview of the current evidence M Buchynskyi, I Kamyshna, V Oksenych, N Zavidniuk, A Kamyshnyi Preprints, 2023 | | 2023 |
| ІМУНОЛОГІЧНІ ОСОБЛИВОСТІ ХРОНІЧНОГО РЕЦИДИВНОГО АФТОЗНОГО СТОМАТИТУ ТА УДОСКОНАЛЕННЯ ЛІКУВАННЯ М Бучинський, О Воробель THE 23d INTERNATIONAL MEDICAL CONGRESS OF STUDENTS AND YOUNG SCIENTISTS, 193, 2019 | | 2019 |
| АНАЛІЗ ЧАСТОТИ ВИЯВЛЕННЯ ВІРУСІВ РЕСПІРАТОРНОЇ ГРУПИ СЕРЕД НАСЕЛЕННЯ В ТЕРНОПІЛЬСЬКІЙ ОБЛАСТІ ЗА 2010-2016 РОКИ М Бучинський THE 23d INTERNATIONAL MEDICAL CONGRESS OF STUDENTS AND YOUNG SCIENTISTS, 60, 2019 | | 2019 |
Valentyn OksenychResearcher, The University of BergenVerified email at uib.no